LATEST
There are no tropical cyclones at this time.✦Messi to retire from Argentina national team✦32 teams, 96 bets: NFL bets to make right now✦GHMC Reviews Ganesh Utsav Arrangements✦S&P 500 gainers: Today’s top performers ranked by Quant✦
Mon, Aug 31, 2026
Loading weather...
Business

Protagonist Therapeutics, Inc. (PTGX) Discusses FDA Approval of Mimrylo for Erythrocytosis in Polycythemia Vera - Slideshow

By Dhallo News · August 31, 2026 at 8:31 PM IST

More details on this developing story will follow.

Original reporting: Seeking Alpha - Stock IdeasRead original report →
Have feedback on this article?Report error or suggestion

Read More from Business

S&P 500 gainers: Today’s top performers ranked by Quant

Breaking News......

Read Article »

Trump’s Latest Tariffs: How He’s Keeping His Trade Wall in Place

From the start of his second term, US President Donald Trump made clear he would...

Read Article »

Funko highest quant-rated stock amid small-cap consumer discretionary firms; Kodiak AI scores lowest

Breaking News......

Read Article »
Return to Front Page

Subscribe to Our Newsletter

Get the latest breaking news and top stories delivered straight to your inbox.